Nevro Corp NVRO:NYSE

Last Price$52.93Cboe Real-Time Last Sale as of 3:36PM ET 8/15/22
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change+1.24(2.40%)
Bid (Size)$52.88 (100)
Ask (Size)$53.00 (32)
Day Low / High$51.30 - 53.34
Volume216.9 K
 

View Medical Specialties IndustryPeer Comparison as of 08/15/2022

 

Nevro Corp ( NYSE )

Price: $52.93
Change: +1.24 (2.40%)
Volume: 216.9 K
3:36PM ET 8/15/2022
 
 

Celldex Therapeutics Inc ( NASDAQ )

Price: $37.85
Change: +0.52 (1.39%)
Volume: 247.9 K
3:35PM ET 8/15/2022
 
 

Silk Road Medical Inc ( NASDAQ )

Price: $49.14
Change: +1.00 (2.08%)
Volume: 154.9 K
3:36PM ET 8/15/2022
 
 

Transmedics Group Inc ( NASDAQ )

Price: $47.85
Change: +0.85 (1.81%)
Volume: 196.5 K
3:33PM ET 8/15/2022
 
 

Avanos Medical Inc ( NYSE )

Price: $29.61
Change: +0.52 (1.77%)
Volume: 208.0 K
3:36PM ET 8/15/2022
 

Read more news Recent News

--Wells Fargo Securities Adjusts Nevro's Price Target to $86 From $90, Reiterates Overweight Rating
12:31PM ET 8/04/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

--Piper Sandler Adjusts Nevro's Price Target to $45 From $64, Maintains Neutral Rating
6:50AM ET 8/04/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

-- Earnings Flash (NVRO) NEVRO Posts Q2 Revenue $104.2M
4:31PM ET 8/03/2022 MT Newswires

...

-- Earnings Flash (NVRO) NEVRO Posts Q2 Revenue $104.2M
4:31PM ET 8/03/2022 MT Newswires

...

Company Profile

Business DescriptionNevro Corp. engages in the provision of medical devices. The firm focuses on providing products that improve the quality of life of patients suffering from debilitating chronic pain. It develops and commercializes senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company was founded by Konstantinos Alataris in March 2006 and is headquartered in Redwood City, CA. View company web site for more details
Address1800 Bridge Parkway
Redwood City, California 94065
Phone+1.650.251.0005
Number of Employees804
Recent SEC Filing08/08/20224
Chairman, President & Chief Executive OfficerD. Keith Grossman
Chief Financial OfficerRoderick H. MacLeod
Chief Medical OfficerDavid Caraway
Vice President-Technical OperationsChristopher Christoforou

Company Highlights

Price Open$51.40
Previous Close$51.69
52 Week Range$39.41 - 127.97
Market Capitalization$1.9 B
Shares Outstanding35.4 M
SectorHealth Technology
IndustryMedical Specialties
Next Earnings Announcement11/14/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$3.58
Beta vs. S&P 500N/A
Revenue$387.3 M
Net Profit Margin-35.96%
Return on Equity-51.05%

Analyst Ratings as of 07/11/2022

Buy
3
Overweight
0
Hold
9
Underweight
1
Sell
1
Consensus RecommendationConsensus Icon
Powered by Factset